Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?

Publication
Article
BioPharm InternationalBioPharm International-03-15-2002
Volume 15
Issue 3

by Jill Wechsler, pp. 55-57, 60 The industry must ensure that manufacturing systems can produce high quality and consistent therapies, efforts that may lead to comparable "subsequent entry" products.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.